Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.

Initiation of coagulation by tissue factor (TF) is a potentially powerful regulator of local inflammatory responses. We hypothesized that blockade of TF-factor VIIa (FVIIa) complex would decrease lung inflammation and proinflammatory cytokine release after tracheal instillation of Escherichia coli lipopolysaccharide (LPS 0111:B4). At the time of injury, rats received one dose of site-inactivated FVIIa (FFR-FVIIa) or saline intravenously. At 0, 6,12, 24, and 48 h after injury, lungs were examined for histologic changes and bronchoalveolar lavage (BAL) was performed to assess protein, lactate dehydrogenase (LDH) activity, cell counts, and cytokine levels. LPS-injured rats treated with FFR-FVIIa showed decreased intra-alveolar inflammation and fibrin deposition by light microscopy compared with untreated rats. This was accompanied by decreased protein leakage (P < 0.0001), LDH activity (P < 0.0001), and local elaboration of interleukin (IL)-1beta, IL-6, and IL-10 (all P < 0.0001), but not tumor necrosis factor (TNF)-alpha. Protection was associated with reduction of TF mRNA expression in whole lung, but not with changes in nuclear translocation of nuclear factor (NF)-kappaB. FFR-FVIIa given 6 h after LPS afforded equivalent lung protection. Therefore, blockade of TF-FVIIa complex protects the lung from injury by LPS in part by reducing local expression of proinflammatory cytokines and may offer promise for therapy of acute lung injury.

[1]  M. Carraway,et al.  Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. , 2001, American journal of respiratory and critical care medicine.

[2]  J. Roman,et al.  Transcriptional regulation of the human interleukin 1beta gene by fibronectin: role of protein kinase C and activator protein 1 (AP-1). , 2000, Cytokine.

[3]  T. van der Poll,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation , 2022 .

[4]  J. Herbert,et al.  Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[5]  P. Freskgård,et al.  Exclusion of Known Protease Activated Receptors in Factor VIIa-induced Signal Transduction , 2000, Thrombosis and Haemostasis.

[6]  A. M. Lefer,et al.  Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB. , 1999, Anesthesiology.

[7]  H. Prydz,et al.  Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene* , 1999, The Journal of Biological Chemistry.

[8]  P. Freskgård,et al.  Factor VIIa-induced p44/42 Mitogen-activated Protein Kinase Activation Requires the Proteolytic Activity of Factor VIIa and Is Independent of the Tissue Factor Cytoplasmic Domain* , 1999, The Journal of Biological Chemistry.

[9]  G. Hunninghake,et al.  Both Erk and p38 kinases are necessary for cytokine gene transcription. , 1999, American journal of respiratory cell and molecular biology.

[10]  T. Nakajima,et al.  Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-κB activation in synovial fibroblasts , 1999, Annals of the rheumatic diseases.

[11]  A. Lefer,et al.  Tissue Factor Expression in Vital Organs during Murine Traumatic Shock Role of Transcription Factors AP-1 and NF-κB , 1999 .

[12]  V. Hjortdal,et al.  Local application of FFR‐rFVIIa reduces thrombus formation at arterial anastomosis in rats , 1999, Microsurgery.

[13]  H. Hemker,et al.  Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. , 1998, Journal of immunology.

[14]  J. Oliver,et al.  Active Site-inactivated Factors VIIa, Xa, and IXa Inhibit Individual Steps in a Cell-based Model of Tissue Factor-initiated Coagulation , 1998, Thrombosis and Haemostasis.

[15]  L. Poulsen,et al.  Signal Transduction via the Mitogen-activated Protein Kinase Pathway Induced by Binding of Coagulation Factor VIIa to Tissue Factor* , 1998, The Journal of Biological Chemistry.

[16]  A. Chang,et al.  Active Site Inhibited Factor VIIa (DEGR VIIa) Attenuates the Coagulant and Interleukin-6 and -8, but not Tumor Necrosis Factor, Responses of the Baboon to LD100 Escherichia coli , 1998 .

[17]  A. Chang,et al.  Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. , 1998, Blood.

[18]  D. Männel,et al.  Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.

[19]  D. Altieri,et al.  Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. , 1997, The Journal of clinical investigation.

[20]  P. Freskgård,et al.  Incorporation of an Active Site Inhibitor in Factor VIIa Alters the Affinity for Tissue Factor* , 1997, The Journal of Biological Chemistry.

[21]  A. Dackiw,et al.  VLA-4 Integrin Cross-linking on Human Monocytic THP-1 Cells Induces Tissue Factor Expression by a Mechanism Involving Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[22]  N. Mackman,et al.  Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[23]  D. Männel,et al.  Role of NF k B in the Mortality of Sepsis , 1997 .

[24]  J. Røttingen,et al.  Coagulation Factors VII and X Induce Ca2+ Oscillations in Madin-Darby Canine Kidney Cells Only When Proteolytically Active* , 1996, The Journal of Biological Chemistry.

[25]  E. Goormaghtigh,et al.  Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein , 1996, The Journal of Biological Chemistry.

[26]  P. Suter,et al.  Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. , 1996, American journal of respiratory and critical care medicine.

[27]  P. Shapiro,et al.  The Seven-transmembrane-spanning Receptors for Endothelin and Thrombin Cause Proliferation of Airway Smooth Muscle Cells and Activation of the Extracellular Regulated Kinase and c-Jun NH-terminal Kinase Groups of Mitogen-activated Protein Kinases (*) , 1996, The Journal of Biological Chemistry.

[28]  D. Payen,et al.  Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. , 1996, American journal of respiratory and critical care medicine.

[29]  M. Ultsch,et al.  The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. , 1996, Journal of molecular biology.

[30]  Ruo-Pan Huang,et al.  Transcriptional Regulation of the Tissue Factor Gene in Human Epithelial Cells Is Mediated by Sp1 and EGR-1 (*) , 1996, The Journal of Biological Chemistry.

[31]  Sandrine,et al.  Thrombm and trypsm-induced Ca mobilization m human T celllines through interaction with different protease-activated receptors , 2020 .

[32]  Jack Benner,et al.  Activation of Glycosylasparaginase , 1996, The Journal of Biological Chemistry.

[33]  J. Maraganore,et al.  Hirulog effect in rat endotoxin shock. , 1995, Life sciences.

[34]  J. Bryant,et al.  Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. , 1995, JAMA.

[35]  C. Haslett,et al.  Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. , 1995, Blood.

[36]  P. Conlon,et al.  Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS , 1995, Infection and immunity.

[37]  R. Frazier,et al.  Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. , 1994, Circulatory shock.

[38]  S. Idell.  Extravascular coagulation and fibrin deposition in acute lung injury. , 1994, New horizons.

[39]  C. Rosen,et al.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site , 1994, Molecular and cellular biology.

[40]  J. Repine,et al.  Intratracheal but not intravascular interleukin-1 causes acute edematous injury in isolated neutrophil-perfused rat lungs through an oxygen radical-mediated mechanism. , 1994, The Journal of laboratory and clinical medicine.

[41]  T. van der Poll,et al.  Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. , 1994, The Journal of clinical investigation.

[42]  S. Akira,et al.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Chang,et al.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. , 1993, The Journal of clinical investigation.

[44]  A. Issekutz,et al.  Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[45]  S. Suter,et al.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. , 1992, The American review of respiratory disease.

[46]  C. Esmon,et al.  DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. , 1991, Blood.

[47]  T. Ulich,et al.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. , 1991, The American journal of pathology.

[48]  F. Taylor,et al.  Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. , 1991, Circulatory shock.

[49]  K. Mitomo,et al.  Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines , 1990, Molecular and cellular biology.

[50]  T. Martin,et al.  Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. , 1989, The Journal of clinical investigation.

[51]  G. Mandell,et al.  Both Recombinant Interleukin‐1 (Beta) and Purified Human Monocyte Interleukin‐1 Prime Human Neutrophils for Increased Oxidative Activity and Promote Neutrophil Spreading , 1989, Journal of leukocyte biology.

[52]  H. Chapman,et al.  Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. , 1986, The American review of respiratory disease.

[53]  R. Senior,et al.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. , 1986, The Journal of clinical investigation.

[54]  K. Sueishi,et al.  Permeability Enhancing and Chemotactic Activities of Lower Molecular Weight Degradation Products of Human Fibrinogen , 1981, Thrombosis and Haemostasis.

[55]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.